Open Health names new director of rare diseases

Open Health has announced the appointment of Gavin Jones as its new director of rare diseases.

The newly-created role will see Mr Jones work in close partnership with pH Associates and other Open Health agencies to drive existing and future partnerships with customers working in this growing field.

He can boast 20 years of biopharmaceutical industry experience across numerous roles involved in market access, therapy launch and patient-centric services, as well as a specialist interest in rare disease that makes him ideally suited for this role.

Open Health hopes that creating this specialist role will enable the firm to offer a market-leading position in helping customers work towards greater access and uptake of innovative treatments.

Sandy Royden, joint chief executive officer of Open Health, said: "We already have significant experience in rare disease and Gavin's appointment will allow us to reach even higher levels of coordinated expertise across all of our agencies."

With over 20 years of experience within marketing, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current marketing roles we have available, you can search for the latest job roles, register your details, or contact the team today.